Overview

Liraglutide Effects on Memory in Healthy Subjects

Status:
Completed

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

This study examines the hypothesis, that subcutaneous administration of liraglutide, an analogue of the incretin glucagon-like peptide 1, over 5 weeks improves memory functions in healthy humans.

Phase:

Phase 1

Details

Lead Sponsor:

University of Luebeck

Collaborator:

Novo Nordisk A/S

Treatments:

Liraglutide